Location: Menlo Park, CA
CIK: 0001631134 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Nov 13, 2024
Total Value: $1.26B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| NTRA | Natera Inc | 1,550,280 | $197M | 15.6% | $126.95 * | $9.81 | +1070.5% | COM | 632307104 |
| VERA | Vera Therapeutics Inc | 2,793,987 | $123M | 9.8% | $44.20 * | $15.35 | +147.2% | CL A | 92337R101 |
| NVO | Novo-Nordisk A S | 726,329 | $86.48M | 6.9% | $119.07 | $128.16 | — | ADR | 670100205 |
| AZN | AstraZeneca PLC | 809,406 | $63.06M | 5.0% | $77.91 | $73.21 | — | SPONSORED ADR | 046353108 |
| IDYA | IDEAYA Biosciences Inc | 1,749,455 | $55.42M | 4.4% | $31.68 * | $31.22 | +21.5% | COM | 45166A102 |
| ELAN | Elanco Animal Health Inc | 3,518,684 | $51.69M | 4.1% | $14.69 * | $13.98 | -0.4% | COM | 28414H103 |
| BIOA | BioAge Labs Inc | 2,304,901 | $47.94M | 3.8% | $20.80 * | $20.04 | 0.0% | COM | 09077V100 |
| INCY | Incyte Corp | 714,176 | $47.21M | 3.7% | $66.10 * | $63.77 | 0.0% | COM | 45337C102 |
| RAPP | Rapport Therapeutics Inc | 1,995,594 | $40.87M | 3.2% | $20.48 * | $23.12 | -7.0% | COM | 75383L102 |
| AVBP | Arrivent BioPharma Inc | 1,696,752 | $39.87M | 3.2% | $23.50 * | $20.17 | +12.5% | COM | 04272N102 |
| AXSM | Axsome Therapeutics Inc | 379,527 | $34.11M | 2.7% | $89.87 * | $76.46 | +14.2% | COM | 05464T104 |
| SLNO | Soleno Therapeutics Inc | 586,344 | $29.6M | 2.3% | $50.49 * | $43.38 | +10.4% | COM | 834203309 |
| — | Y-mAbs Therapeutics Inc | 2,194,278 | $28.85M | 2.3% | $13.15 | $26.75 | — | COM | 984241109 |
| DYN | Dyne Therapeutics Inc | 772,070 | $27.73M | 2.2% | $35.92 * | $16.48 | +141.5% | COM | 26818M108 |
| COGT | Cogent Biosciences Inc | 2,265,230 | $24.46M | 1.9% | $10.80 * | $6.37 | +52.8% | COM | 19240Q201 |
| SVRA | Savara Inc | 5,662,550 | $24.01M | 1.9% | $4.24 * | $4.16 | +6.1% | COM | 805111101 |
| NVS | Novartis AG | 200,000 | $23M | 1.8% | $115.02 | — | — | Put | 66987V109 |
| — | Inozyme Pharma Inc | 4,280,308 | $22.39M | 1.8% | $5.23 | $14.88 | — | COM | 45790W108 |
| JAZZ | Jazz Pharmaceuticals PLC | 188,562 | $21.01M | 1.7% | $111.41 | $109.58 | 0.0% | SHS USD | G50871105 |
| INSM | Insmed Inc | 286,307 | $20.9M | 1.7% | $73.00 | $45.95 | +60.6% | COM PAR $.01 | 457669307 |
| SNDX | Syndax Pharmaceuticals Inc | 786,999 | $15.15M | 1.2% | $19.25 * | $21.11 | -2.1% | COM | 87164F105 |
| SLNO | Soleno Therapeutics Inc | 300,000 | $15.15M | 1.2% | $50.49 * | $43.38 | +10.4% | Put | 834203309 |
| RYTM | Rhythm Pharmaceuticals | 276,678 | $14.5M | 1.2% | $52.39 * | $47.92 | 0.0% | COM | 76243J105 |
| AXSM | Axsome Therapeutics Inc | 150,000 | $13.48M | 1.1% | $89.87 * | $76.46 | +14.2% | Put | 05464T104 |
| EW | Edwards Lifesciences Corp | 202,898 | $13.39M | 1.1% | $65.99 * | $88.55 | -18.0% | COM | 28176E108 |
| BSX | Boston Scientific Corp | 135,819 | $11.38M | 0.9% | $83.80 * | $60.26 | +30.8% | COM | 101137107 |
| PHVS | Pharvaris N V | 600,302 | $11.12M | 0.9% | $18.52 | $21.02 | -13.1% | COM | N69605108 |
| EWTX | Edgewise Therapeutics Inc | 384,767 | $10.27M | 0.8% | $26.69 * | $17.44 | +14.1% | COM | 28036F105 |
| IMNM | Immunome Inc | 676,766 | $9.894M | 0.8% | $14.62 * | $19.68 | -27.8% | COM | 45257U108 |
| GH | Guardant Health Inc | 406,645 | $9.328M | 0.7% | $22.94 * | $28.30 | 0.0% | COM | 40131M109 |
| RVMD | Revolution Medicines Inc | 203,271 | $9.218M | 0.7% | $45.35 * | $37.38 | +16.5% | COM | 76155X100 |
| INBX | Inhibrx Biosciences Inc | 536,068 | $8.395M | 0.7% | $15.66 * | $15.41 | -8.8% | COM | 45720N103 |
| TGTX | TG Therapeutics Inc | 358,644 | $8.389M | 0.7% | $23.39 * | $15.93 | +37.1% | COM | 88322Q108 |
| — | Aerovate Therapeutics Inc | 3,758,686 | $7.856M | 0.6% | $2.09 | $22.83 | — | COM | 008064107 |
| ESTA | Establishment Labs Hldgs Inc | 181,476 | $7.852M | 0.6% | $43.27 | $47.17 | -7.8% | COM | G31249108 |
| — | Marinus Pharmaceuticals Inc | 4,386,177 | $7.72M | 0.6% | $1.76 | $3.60 | — | COM | 56854Q200 |
| JANX | Janux Therapeutics Inc | 164,770 | $7.486M | 0.6% | $45.43 * | $43.50 | 0.0% | COM | 47103J105 |
| CABA | Cabaletta Bio Inc | 1,533,883 | $7.24M | 0.6% | $4.72 * | $12.21 | -52.6% | COM | 12674W109 |
| ACHV | Achieve Life Sciences Inc | 1,514,032 | $7.177M | 0.6% | $4.74 * | $4.45 | +2.7% | COM | 004468500 |
| KURA | Kura Oncology Inc | 296,884 | $5.801M | 0.5% | $19.54 * | $14.03 | +44.4% | COM | 50127T109 |
| PAHC | Phibro Animal Health Corp | 238,184 | $5.364M | 0.4% | $22.52 * | $16.07 | +20.1% | CL A COM | 71742Q106 |
| ILMN | Illumina Inc | 40,611 | $5.296M | 0.4% | $130.41 * | $123.37 | 0.0% | COM | 452327109 |
| ERAS | Erasca Inc | 1,842,668 | $5.03M | 0.4% | $2.73 * | $2.21 | +27.5% | COM | 29479A108 |
| IMTX | Immatics N.V | 386,100 | $4.405M | 0.3% | $11.41 * | $9.86 | +20.1% | SHS | N44445109 |
| — | Inari Med Inc | 90,327 | $3.725M | 0.3% | $41.24 | $48.14 | — | COM | 45332Y109 |
| BDX | Becton Dickinson & Co | 15,191 | $3.663M | 0.3% | $241.10 * | $227.63 | 0.0% | COM | 075887109 |
| — | Nextcure Inc | 2,671,856 | $3.66M | 0.3% | $1.37 | $10.01 | — | COM | 65343E108 |
| TMO | Thermo Fisher Scientific Inc | 5,770 | $3.569M | 0.3% | $618.57 * | $589.13 | 0.0% | COM | 883556102 |
| EXAS | Exact Sciences Corp | 37,637 | $2.564M | 0.2% | $68.12 * | $63.25 | -10.8% | COM | 30063P105 |
| IRON | Disc Medicine Inc | 41,352 | $2.032M | 0.2% | $49.14 * | $42.38 | +10.8% | COM | 254604101 |
| — | Bolt Biotherapeutics Inc | 2,754,437 | $1.785M | 0.1% | $0.65 | $32.91 | — | COM | 097702104 |
| GPCR | Structure Therapeutics Inc | 38,792 | $1.703M | 0.1% | $43.89 | $45.34 | — | SPONSORED ADS | 86366E106 |
| CATX | Perspective Therapeutics Inc | 120,632 | $1.61M | 0.1% | $13.35 | $14.46 | -8.0% | COM | 46489V302 |
| RNAM | Avidity Biosciences Inc | 30,472 | $1.4M | 0.1% | $45.93 * | $33.06 | +31.3% | COM | 05370A108 |
| VIR | Vir Biotechnology Inc | 129,246 | $968K | 0.1% | $7.49 * | $8.69 | 0.0% | COM | 92764N102 |
| — | Astria Therapeutics Inc | 85,640 | $943K | 0.1% | $11.01 | $9.66 | — | COM | 04635X102 |
| — | Immatics N.V | 366,568 | $852K | 0.1% | $2.33 | $3.40 | — | *W EXP 07/01/2025 | N44445117 |
| — | Ikena Oncology Inc | 382,616 | $662K | 0.1% | $1.73 | $2.66 | — | COM | 45175G108 |
| REPL | Replimune Group Inc | 48,138 | $528K | 0.0% | $10.96 * | $10.16 | 0.0% | COM | 76029N106 |
| LUNG | Pulmonx Corp | 62,313 | $517K | 0.0% | $8.29 * | $7.67 | -5.7% | COM | 745848101 |